Further characterization of the mechanism of action of FILIP1L on chemosensitivity may help elucidate the role played by FILIP1L in ovarian cancer recurrence and result in the development of more effective treatment regimens. This evidence concerns the gene FILIP1L and ovarian carcinoma.